Novel use of 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative
AssigneeHyundai Pharm Co., Ltd.
InventorsHye Jin Yoo, Hwan Jin Hwang
Life of this patent
Estimating the term…
Abstract
A 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative according to the present invention promotes the expression of the myogenic factors MyoG and MyHC while inhibiting the expression of the muscle atrophy factor atrogin-1, promotes the formation of myotubes, and inhibits myocyte apoptosis, and thus can promote myogenesis and inhibit muscle atrophy.
Claims6
A method for preventing or treating muscle diseases in a subject in need thereof, said method comprising administering a composition comprising a compound of Formula 1, an optical isomer thereof, or a pharmaceutically acceptable salt thereof as an active ingredient,
- wherein the muscle disease includes one or more diseases selected from the group consisting of sarcopenia, muscular atrophy, myasthenia gravis, muscular dystrophy, myotonia, hypotonia, and muscle weakness.
(canceled)
Dependencies are inferred from the claim text.